Media Summary: Mariano de Socarraz and his team at CorePlus Laboratories have been leading the world in adoption of digital Osama Mohamed, MD, PhD, University of California, San Francisco, CA, discusses the latest advances in digital ProCAncer-I results Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I ...

Core Intelligence Ai Driven Decision Support For Prostate Pathology - Detailed Analysis & Overview

Mariano de Socarraz and his team at CorePlus Laboratories have been leading the world in adoption of digital Osama Mohamed, MD, PhD, University of California, San Francisco, CA, discusses the latest advances in digital ProCAncer-I results Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I ... Do you want to know how to assess the performance and features of Dr. Geoff Sonn of Stanford University shares his experience with Unfold Discover how Deep Bio is at the forefront of revolutionizing

Clare Verrill (Nuffield Department of Surgical Sciences, University of Oxford) and members of the ARTICULATE PRO study team, ... Dr. Mahul B. Amin, MD, Clinical Professor of Dr. Christian Fankhauser talks the deep learning approach for automated Gleason grading of Watch Liron Pantanowitz, MD, of the University of Pittsburgh Medical Center (UPMC), discuss the benefits of implementing ... Francisco G. LaRosa, MD, FCAP, explores possible applications for

Photo Gallery

Core Intelligence: AI-Driven Decision Support for Prostate Pathology
Advances in digital pathology and artificial intelligence for prostate cancer
Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support
Study of AI-based Solution for Primary Diagnosis of Prostate Cancer. Delphine Raoux MD, USCAP 2021
Prostate cancer detection: assessing artificial intelligence (AI) software
Episode 93 Highlights - The Artificial Intelligence Revolution in Prostate Cancer Diagnostics
(9) Unfold AI explained by Dr. Geoff Sonn
Deep Bio: Transforming Cancer Diagnosis with AI-Powered Digital Pathology
CorePlus Prostate Artificial Intelligence
Nita Mulliqi: Towards clinically reliable artificial intelligence for prostate cancer pathology
The ARTICULATE PRO study: Studying the transformative role of AI in prostate cancer care
Using AI-driven testing for prostate cancer
View Detailed Profile
Core Intelligence: AI-Driven Decision Support for Prostate Pathology

Core Intelligence: AI-Driven Decision Support for Prostate Pathology

Mariano de Socarraz and his team at CorePlus Laboratories have been leading the world in adoption of digital

Advances in digital pathology and artificial intelligence for prostate cancer

Advances in digital pathology and artificial intelligence for prostate cancer

Osama Mohamed, MD, PhD, University of California, San Francisco, CA, discusses the latest advances in digital

Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support

Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support

ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I ...

Study of AI-based Solution for Primary Diagnosis of Prostate Cancer. Delphine Raoux MD, USCAP 2021

Study of AI-based Solution for Primary Diagnosis of Prostate Cancer. Delphine Raoux MD, USCAP 2021

Study topic: Novel

Prostate cancer detection: assessing artificial intelligence (AI) software

Prostate cancer detection: assessing artificial intelligence (AI) software

Do you want to know how to assess the performance and features of

Episode 93 Highlights - The Artificial Intelligence Revolution in Prostate Cancer Diagnostics

Episode 93 Highlights - The Artificial Intelligence Revolution in Prostate Cancer Diagnostics

Exciting new

(9) Unfold AI explained by Dr. Geoff Sonn

(9) Unfold AI explained by Dr. Geoff Sonn

Dr. Geoff Sonn of Stanford University shares his experience with Unfold

Deep Bio: Transforming Cancer Diagnosis with AI-Powered Digital Pathology

Deep Bio: Transforming Cancer Diagnosis with AI-Powered Digital Pathology

Discover how Deep Bio is at the forefront of revolutionizing

CorePlus Prostate Artificial Intelligence

CorePlus Prostate Artificial Intelligence

CorePlus is the first

Nita Mulliqi: Towards clinically reliable artificial intelligence for prostate cancer pathology

Nita Mulliqi: Towards clinically reliable artificial intelligence for prostate cancer pathology

Title: Towards clinically reliable

The ARTICULATE PRO study: Studying the transformative role of AI in prostate cancer care

The ARTICULATE PRO study: Studying the transformative role of AI in prostate cancer care

Clare Verrill (Nuffield Department of Surgical Sciences, University of Oxford) and members of the ARTICULATE PRO study team, ...

Using AI-driven testing for prostate cancer

Using AI-driven testing for prostate cancer

BERG CEO Niven Narain on how the use of

Next Gen Care: AI and Generative AI Powered Pathology at the Forefront of Prostate Cancer Management

Next Gen Care: AI and Generative AI Powered Pathology at the Forefront of Prostate Cancer Management

Dr. Mahul B. Amin, MD, Clinical Professor of

How Artificial Intelligence is Transforming Precision in the Treatment of Prostate Cancer –163

How Artificial Intelligence is Transforming Precision in the Treatment of Prostate Cancer –163

What happens when

EMUC18: Automated Gleason grading of prostate cancer via deep learning

EMUC18: Automated Gleason grading of prostate cancer via deep learning

Dr. Christian Fankhauser talks the deep learning approach for automated Gleason grading of

The benefits of implementing AI-Based solutions in pathology

The benefits of implementing AI-Based solutions in pathology

Watch Liron Pantanowitz, MD, of the University of Pittsburgh Medical Center (UPMC), discuss the benefits of implementing ...

An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer

An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer

Andrew Armstrong, MD, MS, Duke

The Future of AI in Pathologic Evaluation of Prostate Cancer

The Future of AI in Pathologic Evaluation of Prostate Cancer

Francisco G. LaRosa, MD, FCAP, explores possible applications for

The future of artificial intelligence in prostate cancer

The future of artificial intelligence in prostate cancer

Charles Parker, MBBS, UCL

Multimodal artificial intelligence models in prostate cancer

Multimodal artificial intelligence models in prostate cancer

Charles Parker, MBBS, UCL